Use of FDG-PET/CT for systemic assessment of suspected primary central nervous system lymphoma: a LOC study.

Marc BertauxCaroline HouillierVéronique EdelineMarie-Odile HabertKarima MokhtariAlain GironSébastien BergeretKhe Hoang-XuanNathalie CassouxValérie TouitouSylvain ChoquetCarole SoussainAurélie Kas

Published in: Journal of neuro-oncology (2020)

18FDG-PET/CT detected concomitant occult systemic involvement in a non-negligible proportion of suspected PCNSL cases (8%). In this setting its sensitivity is higher than that of CeCT. All of our patients ultimately diagnosed with concomitant systemic involvement had positive 18FDG-PET/CT. We believe it constitutes a safe one-stop shop evaluation for the systemic pre-treatment imaging of suspected PCNSL.

Keyphrases

pulmonary embolism
end stage renal disease
ejection fraction
newly diagnosed
high resolution
chronic kidney disease
peritoneal dialysis
mass spectrometry
photodynamic therapy
clinical evaluation